Navigation Links
Agilent Technologies and Shimadzu Enable Control of Each Other’s GC Instruments in Their Respective Chromatographic Data Systems
Date:8/25/2014

(PRWEB) August 25, 2014

Agilent Technologies, Inc. and Shimadzu Corp. today announced the release of GC instrument control for their respective Chromatography Data Systems (CDS). This provides customers in analytical laboratories with more freedom of choice when selecting a chromatography data system.

Agilent has released drivers for Shimadzu GC-2010, GC-2010 Plus and GC-2014 integrating to Agilent’s OpenLAB CDS, and Shimadzu has released drivers to control Agilent 6890, 6850, 7820 and 7890 GC instruments in Shimadzu’s LabSolutions. These releases are the result of the joint collaboration--employing RapidControl (RC.NET) instrument drivers--announced in May 2013 to preserve customers’ investments in workflows and operating procedures.

“Agilent continues to follow an open systems approach for the laboratory to deliver value to our customers,” said Bruce von Herrmann, vice president and general manager of Agilent’s Software and Informatics Business. “To reduce costs and enhance the customer experience, we are working with other manufacturers like Shimadzu to enable full and reliable control of lab instrumentation from any CDS. These new releases demonstrate that Rapid Control is the predominant industry standard for analytical instrument control.”

"At Shimadzu, we continue to deploy industry standard drivers for instrument control to provide flexible instrumentation and software solutions for our customers," said Masahito Ueda, Shimadzu general manager of GC & TA Business Unit, Analytical & Measuring Instruments Division. "The adoption and support of RC.NET drivers provide a more integrated solution to customers who require a single CDS product to support seamless multi-vendor control of all instruments in their laboratory."

This move expands control of each other’s instruments to gas chromatography. Since mid-2013, Agilent’s OpenLAB CDS, has supported Shimadzu's Nexera and Prominence HPLC lines and Shimadzu's LabSolutions CDS has supported Agilent's 1100, 1200, 1260 and 1290 series instruments.

For more information about Shimadzu's LabSolutions chromatography systems, visit http://www.shimadzu.com/an/data-net.

For more information about OpenLAB CDS, visit Agilent’s Software & Informatics website.

About Shimadzu Corporation
Founded in 1875, Shimadzu Corporation, a leader in the development of advanced technologies, has a distinguished history of innovation built on the foundation of contributing to society through science and technology. Shimadzu maintains a global network of sales, service, technical support and applications centers on six continents, and has established long-term relationships with a host of highly trained distributors located in over 100 countries. For more information, visit http://www.shimadzu.com.

About Agilent Technologies
Agilent Technologies Inc. is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at http://www.agilent.com.

On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at http://www.agilent.com/go/news.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12112730.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon
2. Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific
3. Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
4. BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite
5. JH Technologies Brings an Expanded Level of Microscope and Imaging Expertise to Industrial Customers in Southern California
6. BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results
7. Pairing old technologies with new for next-generation electronic devices
8. Advancements in OMIC Technologies Drive the Global Bioinformatics Market, According to New Report by Global Industry Analysts, Inc.
9. Pairing old technologies with new for next generation electronic devices
10. Cell Separation Technologies Market Expected to Reach USD 3.3 Billion Globally in 2019: Transparency Market Research
11. Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. (Biohaven) ... company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar Ataxia ... , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is estimated ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... identity. The new Media Cybernetics corporate branding reflects a results-driven revitalization for a ... image analysis. The re-branding components include a crisp, refreshed logo and a new ...
(Date:5/23/2016)... OXFORD, England , May 23, 2016 ... Wednesday, May 25 th at 10:15 a.m. ET before ... about the role genetically engineered mosquitos can play in controlling ... known carrier of the Zika virus.      (Logo: ... genetically engineered male mosquito with a self-limiting gene. Trials in ...
(Date:5/22/2016)... ... 22, 2016 , ... Doctors in Rome say micronutrients found in certain foods ... Surviving Mesothelioma has just posted an article on the new research. Click here ... Clinical Sciences and Translational Medicine evaluated more than 150 studies on polyphenols in cancer ...
Breaking Biology Technology:
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):